Authors

Implementing Headache Training in Residency

Despite a tremendous burden regarding migraine-related disability and expenditure, headache disorders remain underdiagnosed and undertreated, and only a small percentage of patients report satisfaction with the treatment received.

National Women Physicians Day: Janis Miyasaki, Neuropalliative Care, and Advancing Women Leadership

Janis Miyasaki, MD, MEd, FRCPC, FAAN, a pioneer in neuropalliative care, provided clinical thoughts and perspectives on National Women Physicians Day and the ways to promote women leadership within the neurology field.

CAR-T Cell Therapy: Firing Up the Engines as a Possible B-Cell Directed Treatment for MS

Known for his expertise in stem cell transplantation, Cleveland Clinic researcher Jeffrey Cohen, MD, shifted gears to discuss other cell-based therapies in his Whitaker Lecture at the CMSC Annual Meeting.

A Rationale and Step-by-Step Strategy for Including Care Partners in MS Care

Engaging care partners in multiple sclerosis treatment enhances patient outcomes and supports their well-being, fostering healthier care partnerships.

A Doctor Celebrates the Role of Nurse Practitioners in Providing the Highest Caliber Care

Heidi Schwarz, MD, offers her perspective on the role of advanced practice providers in clinical neurological care and the benefit that they provide to practices.

Promise and Challenges of Targeting PACAP to Treat Migraine: Michael Marmura, MD

The director of outpatient care at Jefferson Headache Center weighed in on the future of PACAP as a migraine target and previewed upcoming innovations at the 2025 AHS Annual Meeting. [WATCH TIME: 3 minutes]

ChatGPT: A Promising Tool to Combat Social Isolation and Loneliness in Older Adults With Mild Cognitive Impairment

Recent advances in artificial intelligence—particularly conversational AI tools such as ChatGPT—suggest promising potential in addressing the issues of loneliness and social isolation in these patient populations.

Patient and Clinical Perspectives on Advancing MS Care Through Treatment, Advocacy, and Research

A patient and neurologist discussed personal and professional perspectives on treatment initiation, ongoing research, and patient advocacy in multiple sclerosis. [WATCH TIME: 5 minutes]

Bill Nye on Genetic Testing, Awareness, and the Future of Friedreich Ataxia Care

Bill Nye, science educator and advocate, reflects on Friedreich ataxia awareness, diagnostic challenges, and the evolving role of genetics and communication in advancing care.

The State of Biomarkers in Multiple Sclerosis

As the field of MS care turns its sights on addressing progressive disease, the need for more biomarkers of disease activity and therapeutic target engagement is perhaps greater than ever.

Yale Researchers Shed Light on Epigenetic Differences in Patients with Syphilis and Neurosyphilis

Stroke Intervention: A New Application of Interventional Neuroradiology

New training pathways are needed to close the gap between capable-physician supply and the growing demand for thrombectomy.

Swallow This: Treating Dysphagia with Speech Pathology

Stephanie Richardson, MS, CCC-SLP, an outpatient lead speech-language pathologist at Brooks Rehabilitation, discussed the unique aspects of speech therapy and the pivotal role it plays in helping patients with swallowing and other related functions.

FDA Action Update, Week of August 23, 2026: Authorization, Clinical Hold, and Clearance

Catch up on any of the neurology headlines you may have missed from last week, compiled into 1 place by the NeurologyLive® team.

Justifying Use of CGRP mAbs in Pediatric Patients With Migraine

What happens to the approximately 24% of pediatric patients with migraine who do not respond to the preventive treatments recommended in the AAN guidelines?

Robert Califf, MD, Nominated by Biden Administration as Next FDA Commissioner

Having previously served as head of the organization during the Obama administration, Califf will replace current Acting Commissioner Janet Woodcock, MD.

Aducanumab Reinvigorates the Fight Against Alzheimer Disease

The chief medical officer of ProMIS Neurosciences comments on how aducanumab will help propel innovation needed to drive the next generation of therapies for Alzheimer disease.

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.

Optical Coherence Tomography Angiography Helps Differentiate MS and NMOSD

Although existing research has shown structural differences between multiple sclerosis and neuromyelitis optica spectrum disorder in following optic neuritis, the new report also covers non–optic neuritis eyes.